ENP111: Addressing the Endocrine Workforce Shortage

The endocrine workforce shortage is affecting the lives of endocrinologists and the patients they treat. Many practices would benefit from any support...

ENP110: Hypercortisolism and T2D

ENP109: Anti-Obesity Medications (CME credit available)

ENP108: AI and Robotics in Surgery

ENP107: Compounded Obesity Medications

ENP106: Reversing Bariatric Surgery

ENP105: Tirzepatide and Menopause

ENP104: Hidden Ingredients in Supplements

ENP103: Type 1 Diabetes: Immunotherapies and Early Detection

ENP102: Insulin Delivery Systems (CME credit available)

ENP101: Papillary Thyroid Cancer

ENP100: Growth Hormone Deficiency

ENP99: Fracture Liaison Services

ENP98: Opioids and the Endocrine System

ENP97: Childhood Obesity Treatment

ENP96: Automated Insulin Delivery Systems

There is a lot of interest in automated insulin delivery systems, and they were covered in depth at the Endocrine Society’s Type 1 Diabetes Fellows Se...

ENP95: Environmental Impact on Early Female Puberty

There are plenty of studies showing that chemicals found in the environment can directly impact human health. Some new research finds that certain env...

ENP94: Update on Acromegaly

It’s been a few years, but we are here with an update on acromegaly, covering prevalence, diagnosis, traditional treatment, new therapies, and current...

ENP93: Prioritizing Patient Experience in Managing Diabetes

Host Aaron Lohr talks with Rita Kalyani, MD, professor of medicine at Johns Hopkins University School of Medicine and president-elect of medicine and...

ENP92: Pheochromocytomas

In this episode, we talk about pheochromocytomas. Host Aaron Lohr talks with Nikhitha Chandrashekar, MD, who recently finished her endocrinology fello...

ENP91: Hypothyroidism and Muscle Regeneration

Our bodies typically do a remarkable job of recovering from certain injuries, and thyroid hormone signaling has an essential role to play there. But w...

ENP90: Early Life Stress and Substance Use

We all know that stress leads to a number of negative outcomes. In this episode, we talk about how early life stress may influence youth substance use...

ENP89: Brown Fat and Metabolic Function

In this episode, we talk about brown fat and some new discoveries in how it regulates metabolic function. Joining host Aaron Lohr is Marsel Lino, PhD,...

ENP88: Glucocorticoids in Supplements

Many people take over-the-counter supplements for a variety of reasons, but it isn’t always clear what’s in those supplements. And while they may be i...

ENP87: Short-Term Weight Loss in Adolescents With Obesity

For those of us who try to lose weight at some point in time, we know the frustration of losing weight and feeling good about that, only to see that w...

ENP86: Machine Learning and Steatotic Liver Disease

ENP85: Treat and Reduce Obesity Act

In this episode, we focus on the Treat and Reduce Obesity Act legislation and the obesity epidemic. Host Aaron Lohr talks with U.S. Rep. Raul Ruiz, MD...

ENP84: Fibrodysplasia Ossificans Progressiva

In a special episode, we discuss a complex, rare disease, fibrodysplasia ossificans progressiva, or FOP. Host Aaron Lohr talks with three guests: Eile...

ENP83: Sedentary Time and Physical Activity Effects on Childhood Lipid Levels

We all know that a sedentary lifestyle is not healthy for anyone, but just how strongly is physical activity connected to lipid levels in childhood? H...

ENP82: PFAS

In this episode, we learn about endocrine-disrupting chemicals known as perfluoroalkyl and polyfluoroalkyl substances (PFAS), which break down so slow...

ENP81: Obesity Fellows Program

According to the National Institutes of Health, more than two in five adults have obesity in the United States, and nearly one in three is overweight....

ENP80: Metabolic and Neuroendocrine Effects of Short Sleep

We all know that sleep is important, but sometimes we just don’t get enough. We also know the normal side effects from lack of sleep, but are there ot...

ENP79: Type 1 Diabetes Update

Today’s topic is type 1 diabetes. What are some of the biggest challenges facing us today when it comes to diagnosing and treating type 1 diabetes, an...

ENP78: Post-Cycle Therapy Following Anabolic-Androgenic Steroid Cessation

We know that illicit use of anabolic-androgenic steroids is dangerous, but cessation comes with its own challenges. Today we’re talking about a study...

ENP77: Phthalates and Endocrine Puberty

We look at a study, presented at ENDO 2023, about the endocrine-disrupting chemicals known as phthalates, or plasticizers, and their effects on fetal...

ENP76: Infants and In Utero Exposure to COVID

ENP75: A Case Study on Fungal Sinusitis in T2D

From ENDO 2023, host Aaron Lohr talks with Jayalakshmi Udayasankar, MD, from the Palo Alto Medical Foundation, about her team’s research presented at...

ENP74: Healthy and Unhealthy Obesity

In another dispatch from ENDO 2023, host Aaron Lohr talks with Max Petersen, MD, PhD, from Washington University in St. Louis, about his team’s resear...

ENP73: A Robotic Teriparatide Pill to Treat Osteoporosis

Host Aaron Lohr talks with two researchers at ENDO 2023, Kyle Horlen, DVM, and Joshua Myers, both from Rani Therapeutics, about two presentations they...

ENP72: GHR, Insulin, and Life Span

In another interview from ENDO 2023, host Aaron Lohr talks with Silvana Duran Ortiz, Ph.D., a postdoctoral research fellow at Ohio University, about h...